EU Probing J&J's $400M Deal For Takeda's Surgical Patch
Europe's competition enforcer opened an in-depth investigation on Wednesday into Johnson & Johnson's planned $400 million purchase of a surgical patch from Takeda Pharmaceuticals to examine concerns about the potential impact...To view the full article, register now.
Already a subscriber? Click here to view full article